Amarin Corp Plc (AMRN)

[Atom0aks]

I take those comments as positive. Vascepa is reasonably priced and will impact millions.
There will always be a disconnect with any treatment that a certain % of people can’t afford!
She is right about Harvoni! Price is obscene.
As you pointed out, she specifically mentioned heart care as not being researched enough.

I agree! Which is why I have been recommending waiting until the agenda is published in the Federal Register before vilifying the FDA.